These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 24011579)
21. Hypoxia-inducible factor-1 in human breast and prostate cancer. Kimbro KS; Simons JW Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428 [TBL] [Abstract][Full Text] [Related]
22. Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis. Sun J; Wang Y; Cui W; Lou Y; Sun G; Zhang D; Miao L J Diabetes Res; 2017; 2017():7242384. PubMed ID: 28695133 [TBL] [Abstract][Full Text] [Related]
23. CFTR is involved in the fine tuning of intracellular redox status: physiological implications in cystic fibrosis. Duranton C; Rubera I; Cougnon M; Melis N; Chargui A; Mograbi B; Tauc M Am J Pathol; 2012 Oct; 181(4):1367-77. PubMed ID: 22846720 [TBL] [Abstract][Full Text] [Related]
24. HIF-1α-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism. Fu L; Chen L; Yang J; Ye T; Chen Y; Fang J Carcinogenesis; 2012 Sep; 33(9):1664-73. PubMed ID: 22745382 [TBL] [Abstract][Full Text] [Related]
26. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines. Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893 [TBL] [Abstract][Full Text] [Related]
28. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Brahimi-Horn C; Pouysségur J Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775 [TBL] [Abstract][Full Text] [Related]
29. Integration of oxygen signaling at the consensus HRE. Wenger RH; Stiehl DP; Camenisch G Sci STKE; 2005 Oct; 2005(306):re12. PubMed ID: 16234508 [TBL] [Abstract][Full Text] [Related]
30. Current understanding of HIF in renal disease. Rosenberger C; Rosen S; Heyman SN Kidney Blood Press Res; 2005; 28(5-6):325-40. PubMed ID: 16534228 [TBL] [Abstract][Full Text] [Related]
31. Signalling pathways involved in hypoxia-induced renal fibrosis. Liu M; Ning X; Li R; Yang Z; Yang X; Sun S; Qian Q J Cell Mol Med; 2017 Jul; 21(7):1248-1259. PubMed ID: 28097825 [TBL] [Abstract][Full Text] [Related]
32. Pathophysiological Consequences of HIF Activation: HIF as a modulator of fibrosis. Haase VH Ann N Y Acad Sci; 2009 Oct; 1177():57-65. PubMed ID: 19845607 [TBL] [Abstract][Full Text] [Related]
33. The role of tubulointerstitial injury in chronic renal failure. Becker GJ; Hewitson TD Curr Opin Nephrol Hypertens; 2000 Mar; 9(2):133-8. PubMed ID: 10757217 [TBL] [Abstract][Full Text] [Related]
34. New insights into molecular mechanisms of epigenetic regulation in kidney disease. Mimura I; Tanaka T; Nangaku M Clin Exp Pharmacol Physiol; 2016 Dec; 43(12):1159-1167. PubMed ID: 27560313 [TBL] [Abstract][Full Text] [Related]
35. The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Mimura I; Nangaku M Nat Rev Nephrol; 2010 Nov; 6(11):667-78. PubMed ID: 20877304 [TBL] [Abstract][Full Text] [Related]
36. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Fine LG; Norman JT Kidney Int; 2008 Oct; 74(7):867-72. PubMed ID: 18633339 [TBL] [Abstract][Full Text] [Related]